Calmodulin-Dependent Protein Kinase II 290-309 acetate

TargetMol
Product Code: TAR-TP1271L
Supplier: TargetMol
CodeSizePrice
TAR-TP1271L-1mg1mg£248.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-2mg2mg£375.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-5mg5mg£542.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-10mg10mg£744.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-25mg25mg£1,099.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-50mg50mg£1,452.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-100mg100mg£1,934.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1271L-500mg500mg£3,805.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Further Information

Bioactivity:
Calmodulin-Dependent Protein Kinase II 290-309 acetate is an effective antagonist of Ca2+/calmodulin-dependent protein kinase II (IC50 = 52 nM).
CAS:
0
Formula:
C105H189N31O26S
Molecular Weight:
2333.88
Pathway:
Neuroscience
Purity:
0.967
SMILES:
C[C@@H](C(O)=O)NC([C@@H](CC(C)C)NC([C@@H](CCSC)NC([C@H]([C@@H](O)C)NC([C@@H]([C@H](O)C)NC(C(CC(C)C)NC(C([C@@H](C)CC)NC([C@H](C)NC(CNC([C@@H](CCCCN)NC([C@H](CC(C)C)NC([C@@H](CCCCN)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@H](C)NC([C@@H](CC(N)=O)NC([C@@H](CC1=CC=CC=C1)NC([C@H](CCCCN)NC([C@H](CCCCN)NC([C@@H](N)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O.CC(O)=O
Target:
CaMK

References

Payne ME, et al. Calcium/calmodulin-dependent protein kinase II. Characterization of distinct calmodulin binding and inhibitory domains. J Biol Chem. 1988 May 25;263(15):7190-5.